Skip to search formSkip to main contentSkip to account menu

Crestor

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: Serum level of cholesterol is one of the most vital risk factors for cardiovascular diseases (CVD). Statins are… 
2015
2015
The patient is a 75-year-old housewife, who underwent menopause about 20 years ago. She has a long-standing history of back and… 
2014
2014
The research on patient compliance and efficiency of the use of statins for initial and secondary prevention of cardio-vascular… 
2012
2012
OBJECTIVE To evaluate the effects of domestic rosuvastatin tablets on coronary plaque in the patients with mild-to-moderate… 
2010
2010
An unusually rancorous debate that was recently described by the president of the American Heart Association as “a statistical… 
2008
2008
actions against seven generics manufacturers — Aurobindo, Apotex, Cobalt, Par, Sandoz, Mylan and Sun — who have submitted… 
2004
2004
  • E. Wooltorton
  • 2004
  • Corpus ID: 46171246
Reason for posting: Rosuvastatin (Crestor) is a relatively new cholesterol-lowering drug that has become one of the top-selling… 
Review
2004
Review
2004
Rosuvastatin (Crestor) has been recently launched in Belgium by AstraZeneca. This new statin is indicated for the treatment of… 
2004
2004
Rosuvastatin (Crestor) has been recently launched in Belgium by AstraZeneca. This new statin is indicated for the treatment of…